Widespread Myths About Antibiotics and Infection

Influenza and the common cold are caused by viruses, not bacteria. Antibiotics are specifically designed to target bacterial cell structures — mechanisms that viruses simply do not have. Taking an antibiotic for a viral illness exposes you to side effects and drug interactions without providing any therapeutic benefit. It also contributes to antibiotic resistance in your own body's bacterial communities. If you have the flu, your provider may discuss antiviral medications (which are an entirely different class of drug), rest, and supportive care instead.

Symptom relief often arrives before the infection is fully cleared. The bacteria that survive longest in your system tend to be the hardiest — those most capable of resisting treatment. Ending your course early gives those survivors the opportunity to multiply and potentially create a more resistant, harder-to-treat infection. That said, research has prompted ongoing clinical debate about optimal course lengths for certain infections; some guidelines have shortened recommended durations for specific conditions. The takeaway is simple: follow your provider's instructions exactly, and discuss any changes with them rather than deciding on your own.

Leftover antibiotics are often an incomplete dose from a previous prescription — not enough to clear a new infection. Additionally, the antibiotic prescribed for one infection may be entirely wrong for another type of bacteria. Self-diagnosing and self-medicating delays proper evaluation and may mask symptoms, making accurate diagnosis harder later. Leftover medications should be disposed of through pharmacy take-back programs or as directed on the label, not stored for future use.

Different antibiotics target different types of bacteria through different mechanisms. A broad-spectrum antibiotic is not inherently more effective than a narrow-spectrum one; it simply acts on a wider range of bacterial types, which also means it disrupts more of the body's beneficial bacteria. When a first-line antibiotic does not appear to be working, the clinical response involves identifying the pathogen (often through a culture test) and selecting the most appropriate agent — not escalating to the most powerful available option. Indiscriminate escalation accelerates resistance and increases risk of serious side effects.

When resistant bacteria develop in one person, they can spread to others through direct contact, water systems, and food production. Hospitals and care facilities are particularly vulnerable environments where resistant organisms can cause severe, difficult-to-treat infections. Overuse of antibiotics in agriculture also contributes to the overall resistance burden. Individual choices matter, but so does systemic policy — making responsible personal antibiotic use one piece of a much larger public health effort.